GlassScriptPhysician profile
Jillian Brooks
NPI 1962977520
$1,294.60
in general payments reported to CMS, 2019-2025
19 companies · $65.98 in 2025
The $65.98 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $415 · 2022: $388 · 2023: $273 · 2024: $153 · 2025: $65.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $429.52 | 2021-2023 | Tukysa, Adcetris |
| Abbvie INC. | $213.45 | 2021-2025 | |
| Daiichi Sankyo INC. | $95.29 | 2023-2024 | Enhertu |
| Merck Sharp & Dohme LLC | $68.69 | 2021-2022 | |
| Genentech USA, INC. | $58.47 | 2022-2023 | Columvi, Lunsumio, Polivy |
| Novartis Pharmaceuticals Corporation | $57.24 | 2022-2023 | |
| Celgene Corporation | $55.95 | 2022-2023 | Opdualag |
| Pfizer INC. | $51.37 | 2024 | |
| Amgen INC. | $50.75 | 2021-2022 | |
| Epizyme, INC. | $46.79 | 2021-2023 | Tazverik |
| Janssen Pharmaceuticals, INC | $28.84 | 2022-2023 | Xarelto |
| Janssen Biotech, INC. | $25.98 | 2021 | |
| Karyopharm Therapeutics INC. | $21.89 | 2023 | Xpovio |
| E.R. Squibb & Sons, L.L.C. | $20.66 | 2021 | |
| Eisai INC. | $18.47 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $13.66 | 2021 | |
| Hologic Sales and Service, LLC | $13.00 | 2023 | Coolseal Generator |
| Lilly USA, LLC | $12.98 | 2023 | Verzenio, Jaypirca |
| Myovant Sciences INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.